Reaction Details Report a problem with these data
Target
Interleukin-4
Ligand
BDBM589821
Substrate
n/a
IC50
19.8±n/a nM
Citation
 Strohbach, JW; Akama, T; Blakemore, DC; Jacobs, RT; Jones, P; Limburg, DC; Oderinde, MS; Perry, MA; Plattner, JJ; Torella, RF; Zhou, Y; Yeoh, TY Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors US Patent  US11559538 Publication Date 1/24/2023 
Target
Name:
Interleukin-4
Synonyms:
B-cell stimulatory factor 1 | BSF-1 | Binetrakin | IL-4 | IL4 | IL4_HUMAN | Lymphocyte stimulatory factor 1 | Pitrakinra
Type:
Protein
Mol. Mass.:
17502.15
Organism:
Human
Description:
P05112
Residue:
153
Sequence:
MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS
  
Inhibitor
Name:
BDBM589821
Synonyms:
US11559538, Example 78 | US11559538, Example 79 | US11559538, Example 80
Type:
Small organic molecule
Emp. Form.:
C19H22BNO4S
Mol. Mass.:
371.258
SMILES:
COc1ccc(cc1OC1CCSC1)-c1cncc(c1)C1COB(O)C1
Structure:
Search PDB for entries with ligand similarity: